Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-26 Sale | 2024-06-27 8:00 pm | KALA BIO Inc. | KALA | Brazzell Romulus K SEE REMARKS | 5,489 | $4.75 | $26,073 | 83,982 (Direct) | View |
| 2024-05-31 Sale | 2024-06-03 8:00 pm | KALA BIO Inc. | KALA | Brazzell Romulus K SEE REMARKS | 2,002 | $6.09 | $12,192 | 89,471 (Direct) | View |
| 2024-01-04 Sale | 2024-01-05 4:05 pm | KALA BIO Inc. | KALA | Brazzell Romulus K SEE REMARKS | 1,617 | $6.74 | $10,899 | 120,773 (Direct) | View |
| 2023-01-04 Sale | 2023-01-06 8:00 pm | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 73 | $28.53 | $2,083 | 18,536 (Direct) | View |
| 2022-10-26 Sale | 2022-10-28 4:15 pm | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 261 | $6.51 | $1,699 | 5,809 (Direct) | View |
| 2022-06-27 Sale | 2022-06-29 8:11 pm | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 3,144 | $0.37 | $1,163 | 285,201 (Direct) | View |
| 2022-01-04 Sale | 2022-01-05 8:00 pm | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 3,504 | $1.3 | $4,555 | 526,345 (Direct) | View |
| 2021-10-26 Sale | 2021-10-28 8:02 pm | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K CHIEF MEDICAL OFFICER | 12,757 | $1.8 | $22,963 | 291,849 (Direct) | View |
| 2021-06-28 Sale | 2021-06-29 5:26 pm | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K CHIEF MEDICAL OFFICER | 3,034 | $5.77 | $17,506 | 300,962 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-04 Option Award | 2024-01-05 4:05 pm | N/A 2034-01-03 | KALA BIO Inc. | KALA | Brazzell Romulus K SEE REMARKS | 35,800 | $0 | 120,773 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 115,164 | $0 | 151,616 (Direct) | View |
| 2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2025-10-02 | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 17,916 | $0 | 36,452 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 17,916 | $0 | 36,452 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 576 | $0 | 576 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-06 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 12,800 | $0 | 18,536 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS | 238,000 | $0 | 526,345 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 4:59 pm | N/A 2031-01-03 | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer | 137,500 | $0 | 413,996 (Direct) | View |
| 2020-10-26 Option Award | 2020-10-28 8:28 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer | 81,000 | $0 | 276,496 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 9:47 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer | 19,000 | $0 | 195,496 (Direct) | View |
| 2020-04-09 Exercise | 2020-04-13 08:38 am | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer | 18,247 | $2.3 | 190,004 (Direct) | View |
| 2020-04-09 Exercise | 2020-04-13 08:38 am | N/A 2023-05-09 | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer | 67,771 | $0 | 190,004 (Direct) | View |
| 2020-04-09 Exercise | 2020-04-13 08:38 am | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer | 1,880 | $0.68 | 190,004 (Direct) | View |
| 2020-04-09 Exercise | 2020-04-13 08:38 am | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer | 47,644 | $3.34 | 190,004 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 4:12 pm | N/A 2030-01-01 | Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer | 120,000 | $0 | 120,000 (Direct) | View |